Monica Huerta Lopez

Statistics

Publications

Citations

254

H-Index

Active since

2005

Affiliations

Rega Institute for Medical Research(Current)

Monica Huerta Lopez is an author at Rega Institute for Medical Research specializing in chemotherapy resistance, oncology, and cytotoxic chemotherapy.

Publications per year

2005–2014

Publications

Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical Development

Magdalena Ślusarczyk, Monica Huerta Lopez, Jan Balzarini et al. · Journal of Medicinal Chemistry · 2014 · 151 citations

Medicine, Oncology, Pharmacology +16

Cyclooxygenase‐2 inhibitor celecoxib augments chemotherapeutic drug‐induced apoptosis by enhancing activation of caspase‐3 and ‐9 in prostate cancer cells

Devendra S. Dandekar, Monica Huerta Lopez, Robert I. Carey et al. · International Journal of Cancer · 2005 · 103 citations

Medicine, Oncology, Pharmacology +17

1–2 of 2